Cargando…
Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma
Recent advances in genomics, proteomics, bioinformatics and systems biology have unraveled the complex aberrant signaling networks in cancer. The knowledge accrued has dramatically increased the opportunities for discovery of novel molecular targets for drug development. Major emphasis is being laid...
Autores principales: | Matta, Ajay, Ralhan, Ranju |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660327/ https://www.ncbi.nlm.nih.gov/pubmed/19284526 http://dx.doi.org/10.1186/1758-3284-1-6 |
Ejemplares similares
-
14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in Head and Neck cancer cells
por: Macha, Muzafar A, et al.
Publicado: (2010) -
Guggulsterone Targets Smokeless Tobacco Induced PI3K/Akt Pathway in Head and Neck Cancer Cells
por: Macha, Muzafar A., et al.
Publicado: (2011) -
Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma
por: Kitamura, Naoya, et al.
Publicado: (2020) -
Current state and future of photodynamic therapy for the treatment of head and neck squamous cell carcinoma
por: Mimikos, Christina, et al.
Publicado: (2016) -
Nuclear S100A7 Is Associated with Poor Prognosis in Head and Neck Cancer
por: Tripathi, Satyendra Chandra, et al.
Publicado: (2010)